Xpos™

Xpos™

Xpos™

Posaconazole
Antifungals (Systemic Antifungal)

Indication:

Posaconazole is indicated in patients aged 13 years and above for the treatment of following fungal infections: -Invasive aspergillosis in patients with disease that is refractory or intolerant to Amphotericin B or ltraconazole -Fusariosis in patients with disease that is refractory or intolerant to Amphotericin B -Chromoblastomycosis and mycetoma in patients with disease that is refractory or intolerant to ltraconazole -Coccidioidomycosis in patients with disease that is refractory or intolerant to Amphotericin B, ltraconazole or Fluconazole Also indicated for prophylaxis of invasive fungal infections in the following patients: -Patients receiving remiShow more 

Dosage & Administration:

Posaconazole Tablets can be taken with or without food.
Loading Dose: 300 mg (3 Tablets) twice a day on the first day
Maintenance Dose: 300 mg (3 Tablets) once a day from the second day

Duration of therapy should be based on the severity of the underlying disease, recovery from immunosuppression and clinical response.

Preparation:

Each pack contains 10 Tablets in Alu-PVC Blister Packaging.